aap's silver coating patent receives notice of allowance by US Patent and Trademark office

Berlin, (PresseBox) - aap Implantate AG (XETRA: AAQ.DE) announced today that the United States Patent and Trademark Office (USPTO) has issued the notice of allowance for aap's silver coating patent.

This notice represents a significant advancement in aap's strategy to build a coherent trauma portfolio which addresses broad indications as well as unmet customers' needs. The fundamental nature of this technology lies in the property of silver as a coating material for medical devices to prevent biofilm formation and hence reduce infection risk. aap's silver coating as a platform technology can be applied not only to the existing trauma portfolio but also for other orthopedic implants. Such a technology which aims to reduce infection rates directly contributes to improved patient care and represents a major step in saving healthcare costs.

Bruke Seyoum Alemu, COO, comments: "We are excited about this advancement in the development of our silver coating technology which extends our IP protected trauma portfolio. Complementing our existing LOQTEQ® portfolio, silver-coated implants will strengthen aap's strategy to offer added-value trauma products addressing the growing infection care market. We expect to present the results of the first animal trials for local and systemic tolerability in the second quarter of 2014."

aap plans to submit the technology for regulatory approval within 12-15 months, which would allow first EU market introduction in 2015.

aap Implantate AG

aap ist ein weltweit tätiges Medizintechnikunternehmen mit Sitz in Berlin, Deutschland, das innovative Biomaterialien und Implantate entwickelt, herstellt und vermarktet, die in der Orthopädie eingesetzt werden. Die Produkte des Unternehmens, darunter eine vollständige Produktpalette an Plattensystemen, Lochschrauben und Knochenzementprodukten, werden in erster Linie in den orthopädischen Spezialbereichen Trauma und Wirbelsäule eingesetzt. Vertrieben werden die Produkte im Direktverkauf sowie über Vertriebspartner und Lizenzvereinbarungen mit OEM-Partnern. Die aap-Aktie ist im Prime Standard der Frankfurter Wertpapierbörse notiert. Weitere Informationen finden Sie im Internet unter www.aap.de, oder laden Sie sich die Unternehmens-Investor Relations-app aus dem Apple's App Store oder von Google Play herunter.

Press releases you might also be interested in

Subscribe for news

The subscribtion service of the PresseBox informs you about press information of a certain topic by your choice at a choosen time. Please enter your email address to receive the email with the press releases.

An error occurred!

Thank you! You will receive a confirmation email within a few minutes.


I want to subscribe to the gratis press mail and have read and accepted the conditions.